| ... | 
| ... |
 |
Head,
Retrovirus Gene Expression Section
HIV Drug Resistance Program
National
Cancer Institute
NCI-Frederick, P.O. Box B, Building 535
Frederick, MD
21702-1201
Phone: 301-846-5611
Fax: 301-846-6863
E-mail: derse@ncifcrf.gov
|
Dr. David Derse earned his Ph.D. in 1982 from the State University of New York at Buffalo, studying inhibitors of herpesvirus and cellular DNA polymerases in the laboratory of Dr. Yung-Chi Cheng. Dr. Derse did his postdoctoral research on bovine leukemia virus gene regulation under the supervision of Dr. James W. Casey at the Louisiana State University Medical Center. After joining the National Cancer Institute in 1986 as a Senior Staff Fellow, Dr. Derse continued research on the Tax and Rex proteins encoded by deltaretroviruses. In 1991, he became a tenured Senior Investigator and extended his research into comparative biochemical analyses of lentivirus Tat and Rev proteins. In 2004, Dr. Derse joined the HIV Drug Resistance Program as Head of the Retrovirus Gene Expression Section. He is also an Adjunct Professor in the Graduate Program in Genetics at George Washington University in Washington, D.C. Dr. Derse currently serves on the Editorial Board of Retrovirology and the Executive Committee of the Center of Excellence in HIV/AIDS and Cancer Virology, Center for Cancer Research. His current work focuses on the molecular mechanisms of HIV-1 and HTLV-1 infection and replication.
| | ... |
|
